Gulbrandsen Technologies is currently building a new facility for the production of aluminum-based adjuvants at its current site in Gujarat, India – strictly compliant with cGMP regulations for the manufacture of sterile vaccine adjuvants, targeting both human and veterinary applications. According to company president, Vikram Singhal, Gulbrandsen Technologies has been making the world a better…